Fund Stats as of 02/15/2019
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $33.95
Last Trade Price $33.92
NAV $33.95
NAV Change $0.72
Total Net Assets $186,715,393
Total Market Value $174,090,265
Premium/Discount(%) 0.00%
Difference ($) $0.00
Volume 37,359
Shares Outstanding 5,500,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  


as of 01/31/2019
as of 12/31/2018
Fund1 Mo.3 Mo.YTDS.I.1 Yr.3 Yr.S.I.
ALPS Medical Breakthroughs ETF (Net Asset Value)13.53%-2.12%13.53%36.13%-11.20%-2.36%4.64%
ALPS Medical Breakthroughs ETF (Market Price)13.72%-2.57%13.72%35.58%-11.81%-2.52%4.49%
Poliwogg Medical Breakthroughs Index (Benchmark)13.55%-1.92%13.55%38.05%-11.04%-2.08%5.00%
ALPS Medical Breakthroughs ETF (Net Asset Value)
ALPS Medical Breakthroughs ETF (Market Price)
Poliwogg Medical Breakthroughs Index (Benchmark)

Performance data quoted represent past performance. Past performance is no guarantee of future results so that shares, when redeemed may be worth more or less than their original cost. The investment return and principal value will fluctuate. Current performance may be higher or lower than the performance quoted. For the most current month-end performance data please call 844.234.5852. Performance includes reinvested distributions and capital gains.